Estuary Launches with $103 Million for Kidney Gene Therapy
Estuary Biotherapeutics launched with $103 million in total committed financing: a new $93 million Series A led by RA Capital Management plus a previously raised $10 million seed round co-led by 4BIO Capital and…
